CJC 1295 with DAC 5mg

• 3mg vial
• 5mg
• Lyophilized powder

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide and growth hormone-releasing hormone (GHRH) analog designed for research purposes. It is known for its prolonged half-life and ability to stimulate the release of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) by binding to GHRH receptors.

Key Features & Properties:

• Extended Half-Life: The addition of DAC increases the duration of action, enabling sustained GH release over time.

• GH & IGF-1 Stimulation: Encourages the endogenous production of growth hormone, which may support various physiological processes in research models.

• Peptide Stability: Modified structure enhances stability and bioavailability compared to traditional GHRH analogs.

Intended Use:

CJC-1295 with DAC is strictly for in vitro and laboratory research applications. It is not intended for human consumption, medical use, or veterinary purposes. Researchers utilize this compound to study its effects on cellular and metabolic pathways related to growth hormone secretion.